The PARITY team is excited to announce the trial has achieved the 90% enrolment milestone! On March 23rd, the 540th participant was enrolled in the study by Dr. Shah Alam Khan and his research team at All India Institute of Medical Sciences. Thank you for everyone’s commitment in making PARITY trial a success. Remember to continue to screen all new patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the study.
